FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060113725> ?p ?o ?g. }

• W2060113725 endingPage "457" @default.
• W2060113725 startingPage "448" @default.
• W2060113725 abstract "Systemic macrolide antibiotic administration has been shown to result in the elimination or reduction cyclosporine A-induced gingival overgrowth. Roxithromycin (ROX) is known to have anti-inflammatory, immunomodulatory and tissue reparative effects. This study was to evaluate the effect of adjunctive ROX therapy on cyclosporine A-induced gingival overgrowth and interleukin (IL)-1β, transforming growth factor (TGF)-β1 and vascular endothelial growth factor (VEGF) levels in gingival crevicular fluid of renal transplant patients.Thirty-one patients with clinically significant overgrowth and 16 periodontally healthy subjects were included in this randomized, double-blind, placebo-controlled, parallel-arm study. Patients received scaling and root planing (SRP) at baseline and randomized to take either ROX or placebo for 5 d. The clinical parameters, including plaque index, papillary bleeding index, probing depth and gingival overgrowth scores, were recorded. The amounts of IL-1β, TGF-β1 and VEGF in gingival crevicular fluid were detected by ELISA. Periodontal parameters as well as gingival crevicular fluid biomarker levels were evaluated at baseline and at 1 and 4 wk post-therapy.Following SRP plus ROX and SRP plus placebo therapy, significant improvements in clinical periodontal parameters of both study groups were observed (p < 0.025). In the ROX group, adjunctive ROX therapy resulted in a greater gingival overgrowth scores reduction compared with those in the placebo group at 4 wk (p < 0.017). Initial amounts of IL-1β, TGF-β1 and VEGF for both the ROX and placebo groups were significantly higher than those for healthy subjects (p < 0.017), with no statistical difference between the two study groups. At 1 and 4 wk post-therapy, significant decreases in the amounts of IL-1β, TGF-β1 and VEGF were observed in both study groups when compared with baseline (p < 0.025), but there was no difference in the levels of IL-1β and VEGF between the two study groups. The amount of decrease in TGF-β1 levels for the ROX group was statistically significant compared to that for the placebo group at 4 wk after treatment (p < 0.017).Our study indicated that combination of ROX with non-surgical therapy improves gingival overgrowth status and decreases gingival crevicular fluid TGF-β1 levels in patients with severe gingival overgrowth. The reduction of gingival crevicular fluid TGF-β1 following ROX therapy suggests an anti-inflammatory/immunomodulatory effect of ROX on the treatment of cyclosporine A-induced gingival overgrowth." @default.
• W2060113725 created "2016-06-24" @default.
• W2060113725 creator A5004999727 @default.
• W2060113725 creator A5012637312 @default.
• W2060113725 creator A5036035882 @default.
• W2060113725 creator A5054408684 @default.
• W2060113725 date "2013-08-16" @default.
• W2060113725 modified "2023-10-05" @default.
• W2060113725 title "Effect of adjunctive roxithromycin therapy on interleukin‐1β, transforming growth factor‐β1 and vascular endothelial growth factor in gingival crevicular fluid of cyclosporine <scp>A</scp>‐treated patients with gingival overgrowth" @default.
• W2060113725 cites W1505978562 @default.
• W2060113725 cites W1980064779 @default.
• W2060113725 cites W1984645353 @default.
• W2060113725 cites W1984992601 @default.
• W2060113725 cites W1993572702 @default.
• W2060113725 cites W1999798278 @default.
• W2060113725 cites W2003181365 @default.
• W2060113725 cites W2005814113 @default.
• W2060113725 cites W2016790077 @default.
• W2060113725 cites W2017257602 @default.
• W2060113725 cites W2020357859 @default.
• W2060113725 cites W2032119905 @default.
• W2060113725 cites W2040147710 @default.
• W2060113725 cites W2046016153 @default.
• W2060113725 cites W2046853424 @default.
• W2060113725 cites W2048337071 @default.
• W2060113725 cites W2053014384 @default.
• W2060113725 cites W2056817640 @default.
• W2060113725 cites W2057017267 @default.
• W2060113725 cites W2057925891 @default.
• W2060113725 cites W2059606295 @default.
• W2060113725 cites W2062722376 @default.
• W2060113725 cites W2063171445 @default.
• W2060113725 cites W2071107349 @default.
• W2060113725 cites W2075600180 @default.
• W2060113725 cites W2079417833 @default.
• W2060113725 cites W2086380408 @default.
• W2060113725 cites W2091401384 @default.
• W2060113725 cites W2100849338 @default.
• W2060113725 cites W2101221272 @default.
• W2060113725 cites W2103323686 @default.
• W2060113725 cites W2104929377 @default.
• W2060113725 cites W2107228383 @default.
• W2060113725 cites W2109118973 @default.
• W2060113725 cites W2111026515 @default.
• W2060113725 cites W2117869236 @default.
• W2060113725 cites W2121558112 @default.
• W2060113725 cites W2130323934 @default.
• W2060113725 cites W2134311235 @default.
• W2060113725 cites W2140926100 @default.
• W2060113725 cites W2149685466 @default.
• W2060113725 cites W2151356225 @default.
• W2060113725 cites W2151544787 @default.
• W2060113725 cites W2156742440 @default.
• W2060113725 cites W2166312083 @default.
• W2060113725 cites W2167049686 @default.
• W2060113725 cites W2167435614 @default.
• W2060113725 cites W2168853424 @default.
• W2060113725 cites W2171398458 @default.
• W2060113725 cites W2056716047 @default.
• W2060113725 doi "https://doi.org/10.1111/jre.12123" @default.
• W2060113725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23947915" @default.
• W2060113725 hasPublicationYear "2013" @default.
• W2060113725 type Work @default.
• W2060113725 sameAs 2060113725 @default.
• W2060113725 citedByCount "9" @default.
• W2060113725 countsByYear W20601137252016 @default.
• W2060113725 countsByYear W20601137252018 @default.
• W2060113725 countsByYear W20601137252019 @default.
• W2060113725 countsByYear W20601137252020 @default.
• W2060113725 countsByYear W20601137252021 @default.
• W2060113725 countsByYear W20601137252022 @default.
• W2060113725 countsByYear W20601137252023 @default.
• W2060113725 crossrefType "journal-article" @default.
• W2060113725 hasAuthorship W2060113725A5004999727 @default.
• W2060113725 hasAuthorship W2060113725A5012637312 @default.
• W2060113725 hasAuthorship W2060113725A5036035882 @default.
• W2060113725 hasAuthorship W2060113725A5054408684 @default.
• W2060113725 hasConcept C126322002 @default.
• W2060113725 hasConcept C126894567 @default.
• W2060113725 hasConcept C142724271 @default.
• W2060113725 hasConcept C167734588 @default.
• W2060113725 hasConcept C168563851 @default.
• W2060113725 hasConcept C204787440 @default.
• W2060113725 hasConcept C27081682 @default.
• W2060113725 hasConcept C2777025900 @default.
• W2060113725 hasConcept C2778423520 @default.
• W2060113725 hasConcept C2779337755 @default.
• W2060113725 hasConcept C2779416262 @default.
• W2060113725 hasConcept C2780206985 @default.
• W2060113725 hasConcept C2780385504 @default.
• W2060113725 hasConcept C501593827 @default.
• W2060113725 hasConcept C71924100 @default.
• W2060113725 hasConcept C86803240 @default.
• W2060113725 hasConcept C89423630 @default.
• W2060113725 hasConcept C90924648 @default.
• W2060113725 hasConceptScore W2060113725C126322002 @default.
• W2060113725 hasConceptScore W2060113725C126894567 @default.
• W2060113725 hasConceptScore W2060113725C142724271 @default.

• next